This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 20, 2017.(b)(4).Results code: contamination by foreign material.Conclusions code: human factors issue.Upon evaluation of the provided photo, it was confirmed that foreign matter was present on the cr filter within the reservoir.The returned sample was visually inspected, and no foreign matter could be found in the reservoir.A retention sample from 3cx*fx15rw30c lot ul12 was visually inspected and no foreign matter was found within the product.The product undergoes several visual inspections during the manufacturing process, up until packaged into the one-piece box.It is likely that the foreign matter was introduced at some point after removed from the sterilized packaging; however, this was not able to be confirmed.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|